glp-1 and surgery risk Glucagon-Like Peptide-1 Receptor Agonists in Plastic Surgery: Perioperative Considerations Safety Protocols Challenging the Hype: Why GLP-1s

Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds

TB500 enhances cell migration to injury sites, reduces inflammation through cytokine modulation, promotes stem cell differentiation, limits excess scar tissue, and supports angiogenesis

Madhu Karamsetty , Eswar P.R

Body composition in patients with rheumatoid arthritis: a narrative literature review

She wanted a program that supported the healthier, more grounded life she was trying to buildone she could sustain

By simplifying the process, telehealth makes medically supervised weight management more accessible